tiprankstipranks
Clinuvel Appoints New Director, Guy van Dievoet
Company Announcements

Clinuvel Appoints New Director, Guy van Dievoet

Clinuvel Pharmaceuticals Limited (AU:CUV) has released an update.

Don't Miss our Black Friday Offers:

Clinuvel Pharmaceuticals Ltd has announced the appointment of Guy van Dievoet as a new director, effective from September 6, 2024. In accordance with listing rule 3.19A.1, the company disclosed that van Dievoet currently holds no registered securities in the company. The notice also confirmed that the director has no interests in any contracts related to the company at this time.

For further insights into AU:CUV stock, check out TipRanks’ Stock Analysis page.

Related Articles
TipRanks Australian Auto-Generated NewsdeskClinuvel Pursues Expanded SCENESSE® Dosage in Europe
TipRanks Australian Auto-Generated NewsdeskClinuvel Pharmaceuticals Tackles Market Challenges and Opportunities
TipRanks Australian Auto-Generated NewsdeskClinuvel Pharmaceuticals Refocuses on Core Programs for Growth
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App